Markets
-
Century Complete Announces New Homes for Sale in Jacksonville Westside
Century Communities expands its Century Complete brand to Jacksonville’s Westside with Kings Landing, offering affordable single-family homes starting in the upper $200,000s. The community features modern, open-concept floor plans with up to four bedrooms, modern finishes, and included features. Located near downtown Jacksonville, Kings Landing provides convenient access to amenities and major transportation corridors. Century Complete emphasizes online homebuying with local support, streamlining the process for first-time homebuyers.
-
SABA Declares $0.058 Dividend
On November 3, 2025, Saba Capital Income & Opportunities Fund II (SABA) announced a monthly dividend of $0.058 per share, payable November 28, 2025, to shareholders of record on November 11, 2025. The fund operates under a managed distribution plan, potentially using capital gains or return of capital to maintain the fixed payout, which could affect NAV. The plan can be amended or terminated, impacting share price. Investors should review Rule 19a-1 notices and understand the fund’s diverse portfolio and associated risks, detailed in SEC filings.
-
Canada Nickel and UT Austin Launch Carbon Sequestration Pilot at Crawford Nickel Project
Canada Nickel Company launched an in-situ carbon sequestration pilot program at its Crawford Nickel Project, collaborating with the University of Texas and funded by the U.S. Department of Energy. The project aims to accelerate CO2 mineralization by injecting carbon-enriched water into ultramafic rock. Monitoring techniques will track the process, potentially leading to cost reductions and a model for sustainable mining. This initiative complements their existing carbonation program, supporting their net-zero carbon nickel production goal and a Zero-Carbon Industrial Cluster.
-
Infosys Topaz Fabric™ Launches: AI Agent Stack for Enterprise Value
Infosys launched Infosys Topaz Fabric on November 3, 2025, a platform designed to accelerate IT service delivery using AI. The composable architecture integrates data, AI models, and pre-built applications, offering services-as-software for IT operations, transformation, and cybersecurity. Featuring over 50 AI agents, Topaz Fabric aims to automate tasks and augment human capabilities. Nu Skin is already collaborating with Infosys to enhance its IT operations using the platform’s Agent Assist features. The launch addresses the growing demand for AI-driven IT automation.
-
Guardian Metal Resources PLC Announces Update on Garfield Project Exploration
Guardian Metal Resources announced an exploration update for its Garfield gold-silver-copper project in Nevada. Rock chip sampling at the Power Line zone yielded promising results (18.3 g/t Au, 43.6 g/t Ag; 14% Cu, 145 g/t Ag). The company also staked 42 new BLM lode claims over a new Freeze North zone. A 2D IP survey identified a chargeable feature extending 500 meters beneath historic mines in the Freeze/Freeze East zones. Further geophysics and drilling are needed due to alluvial cover.
-
DNOW to Hold Q3 2025 Earnings Call
DNOW Inc. (NYSE: DNOW) will release its Q3 2025 earnings before market open on November 5, 2025, followed by an earnings call at 8:00 AM Central Time. Access the live webcast at ir.dnow.com or dial in using the provided numbers and access code 7372055. DNOW, a major energy and industrial product supplier with a focus on DigitalNOW®, serves diverse sectors and is increasingly focusing on decarbonization, energy evolution, and renewables. Analysts will look for insights into revenue growth in these emerging markets.
-
Faraday Future Taps Chris Nixon Cox as Global Strategic Advisor for “EAI + Crypto” Expansion
Faraday Future (FFAI) appointed Chris Nixon Cox as a global strategic advisor, effective November 3, 2025. Cox will focus on bolstering international expansion by fostering investor relations, navigating governmental affairs, and cultivating industrial cooperation. His role supports FFAI’s “EAI + Crypto” strategy, emphasizing AI-driven innovations and cryptocurrency integration. Cox will join the planned FFAI Global Strategic Advisory Council. This appointment aims to accelerate the company’s global deployment strategy and secure sustainable growth in the EV market.
-
Northern Trust Extends Partnership with Avanda Investment Management for MAS Equity Programme
Northern Trust expands its partnership with Avanda Investment Management to support a mandate from the Monetary Authority of Singapore (MAS) under the Equity Market Development Programme (EQDP). Northern Trust will provide investment operations outsourcing, fund administration, and risk analytics, building on a decade-long relationship. The EQDP is a S$5 billion initiative aimed at strengthening Singapore’s asset management ecosystem. Avanda’s strategy under the EQDP seeks to increase investor access to Singapore-listed equities. This collaboration underscores Northern Trust’s commitment to the Southeast Asian financial market.
-
Alvotech Updates on U.S. BLA for AVT05
Alvotech (ALVO) received a Complete Response Letter from the FDA for its AVT05 biosimilar application, citing deficiencies from a July 2025 facility inspection in Reykjavik. No other application deficiencies were noted, and the facility retains FDA approval for existing product manufacturing. Alvotech submitted a CAPA plan. The company revised its 2025 financial outlook to $570-600 million in revenue and $130-150 million adjusted EBITDA, reflecting facility investments and a temporary production slowdown. US sales of reference product Simponi were <$300M in 1H 2025; no Simponi biosimilar is approved in the US.
-
Caribou Biosciences to Present New Data Updates from Allogeneic CAR-T Programs in Lymphoma and Multiple Myeloma via Webcast
Caribou Biosciences (CRBU) will host a webcast on November 3, 2025, to report clinical data from the ANTLER Phase 1 trial of vispa-cel (CB-010) in relapsed/refractory B-NHL and first-time clinical data from the CaMMouflage Phase 1 trial of CB-011 in relapsed/refractory multiple myeloma. The Company will also outline the Phase 3 trial design for vispa-cel and development plans for CB-011. The webcast will be available live and archived on Caribou’s website.